Browsing Conference Proceeding by Author "Ercegovac, Maja"
Now showing items 1-5 of 5
-
Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy
Dinić, Jelena; Podolski-Renić, Ana; Dragoj, Miodrag; Jovanović Stojanov, Sofija; Stepanović, Ana; Lupšić, Ema; Pajović, Milica; Petrović Rodić, Dušica; Marić, Dragana; Ercegovac, Maja; Pešić, Milica (Elsevier Inc, 2023) -
Functional diagnostics as a new concept for the improvement of personalized targeted therapy
Dragoj, Miodrag; Dinić, Jelena; Podolski-Renić, Ana; Jovanović Stojanov, Sofija; Jovanović, Mirna; Stepanović, Ana; Ercegovac, Maja; Marić, Dragana; Pešić, Milica (STRATAGEM COST Action, 2022) -
High-throughput screening of multidrug-resistance markers in non-small cell lung carcinoma patient-derived cells - contribution to personalized treatment
Jovanović Stojanov, Sofija; Podolski-Renić, Ana; Dinić, Jelena; Dragoj, Miodrag; Jovanović, Mirna; Stepanović, Ana; Lupšić, Ema; Pajović, Milica; Petrović Rodić, Dušica; Marić, Dragana; Ercegovac, Maja; Pešić, Milica (Belgrade: Serbian Association for Cancer Research Belgrade, Serbia, 2023) -
Novel functional immunoassay for identification of multidrug resistance markers in non-small cell lung carcinoma patient-derived cells
Stepanović, Ana; Dinić, Jelena; Podolski-Renić, Ana; Jovanović Stojanov, Sofija; Dragoj, Miodrag; Jovanović, Mirna; Lupšić, Ema; Milićević, Aleksandar; Glumac, Sofija; Marić, Dragana; Ercegovac, Maja; Pešić, Milica (John Wiley and Sons Inc, 2023) -
Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts
Jovanović Stojanov, Sofija; Podolski-Renić, Ana; Dinić, Jelena; Dragoj, Miodrag; Jovanović, Mirna; Stepanović, Ana; Lupšić, Ema; Bajović, Radovan; Glumac, Sofija; Marić, Dragana; Ercegovac, Maja; Pešić, Milica (Elsevier Inc., 2023)